Thursday Jul 24
Nutra Pharma Corp. Announces Infrastructure Improvements To Handle Increased Sales
Nutra Pharma Corp. , a biotechnology company that is developing treatments for Adrenomyeloneuropathy , HIV and Multiple Sclerosis , is announcing that they are in the process of completing critical capital improvements to their warehouse and fulfillment center in order to meet increased demand and shipments of their over-the-counter pain reliever, ... (more)
The Citizens' Voice
Does the rain really cause arthritis pain?
Everybody talks about the weather," Mark Twain said, "but nobody does anything about it."
Nutra Pharma Corp. Announces Completion Of Commercials By MyNyloxin.com
Nutra Pharma Corp. , a biotechnology company that is developing treatments for Adrenomyeloneuropathy , HIV and Multiple Sclerosis , is announcing that MyNyloxin.com, a new company that has the exclusive rights to market and distribute Nutra Pharma's over-the-counter pain reliever, Nyloxin , in the Network Marketing channel has completed their work ... (more)
Nutra Pharma Corp.'s Nyloxin Commercials Begin Airing
Nutra Pharma Corp. saw its share volume soar on June 23rd with 28,388,746 shares exchanging hands, nearly six times higher than its three month daily average volume of 4,838,045 shares.